Advanced search
1 file | 5.52 MB

Limited proteolysis combined with stable isotope labeling reveals conformational changes in protein (pseudo)kinases upon binding small molecules

(2015) JOURNAL OF PROTEOME RESEARCH. 14(10). p.4179-4193
Author
Organization
Abstract
Likely due to conformational rearrangements, small molecule inhibitors may stabilize the active conformation of protein kinases and paradoxically promote tumorigenesis. We combined limited proteolysis with stable isotope labeling MS to monitor protein conformational changes upon binding of small molecules. Applying this method to the human serine/threonine kinase B-Raf, frequently mutated in cancer, we found that binding of ATP or its nonhydrolyzable analogue AMP-PNP, but not ADP, stabilized the structure of both B-Raf(WT) and B-Raf(V600E) The ATP-competitive type I B-Raf inhibitor vemurafenib and the type II inhibitor sorafenib stabilized the kinase domain (KD) but had distinct effects on the Ras-binding domain. Stabilization of the B-Raf(WT) KD was confirmed by hydrogen/deuterium exchange MS and molecular dynamics simulations. Our results are further supported by cellular assays in which we assessed cell viability and phosphorylation profiles in cells expressing B-Raf(WT) or B-Raf(V600E) in response to vemurafenib or sorafenib. Our data indicate that an overall stabilization of the B-Raf structure by specific inhibitors activates MAPK signaling and increases cell survival, helping to explain clinical treatment failure. We also applied our method to monitor conformational changes upon nucleotide binding of the pseudokinase KSR1, which holds high potential for inhibition in human diseases.
Keywords
DRUG DISCOVERY, STRUCTURAL BASIS, MAPK PATHWAY, B-RAF, CANCER, BRAF, RAF KINASE, KINASE INHIBITORS, HYDROGEN-EXCHANGE, EXCHANGE MASS-SPECTROMETRY, small molecule, protein structure, method development, limited proteolysis, inhibitor, KSR1, kinase switch mechanism, kinase, conformational change, B-Raf

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 5.52 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Di Michele, Michela, Elisabeth Stes, Elien Vandermarliere, Rohit Arora, Juan Astorga-Wells, Jonathan Vandenbussche, Erika van Heerde, et al. 2015. “Limited Proteolysis Combined with Stable Isotope Labeling Reveals Conformational Changes in Protein (pseudo)kinases Upon Binding Small Molecules.” Journal of Proteome Research 14 (10): 4179–4193.
APA
Di Michele, M., Stes, E., Vandermarliere, E., Arora, R., Astorga-Wells, J., Vandenbussche, J., van Heerde, E., et al. (2015). Limited proteolysis combined with stable isotope labeling reveals conformational changes in protein (pseudo)kinases upon binding small molecules. JOURNAL OF PROTEOME RESEARCH, 14(10), 4179–4193.
Vancouver
1.
Di Michele M, Stes E, Vandermarliere E, Arora R, Astorga-Wells J, Vandenbussche J, et al. Limited proteolysis combined with stable isotope labeling reveals conformational changes in protein (pseudo)kinases upon binding small molecules. JOURNAL OF PROTEOME RESEARCH. 2015;14(10):4179–93.
MLA
Di Michele, Michela, Elisabeth Stes, Elien Vandermarliere, et al. “Limited Proteolysis Combined with Stable Isotope Labeling Reveals Conformational Changes in Protein (pseudo)kinases Upon Binding Small Molecules.” JOURNAL OF PROTEOME RESEARCH 14.10 (2015): 4179–4193. Print.
@article{6977973,
  abstract     = {Likely due to conformational rearrangements, small molecule inhibitors may stabilize the active conformation of protein kinases and paradoxically promote tumorigenesis. We combined limited proteolysis with stable isotope labeling MS to monitor protein conformational changes upon binding of small molecules. Applying this method to the human serine/threonine kinase B-Raf, frequently mutated in cancer, we found that binding of ATP or its nonhydrolyzable analogue AMP-PNP, but not ADP, stabilized the structure of both B-Raf(WT) and B-Raf(V600E) The ATP-competitive type I B-Raf inhibitor vemurafenib and the type II inhibitor sorafenib stabilized the kinase domain (KD) but had distinct effects on the Ras-binding domain. Stabilization of the B-Raf(WT) KD was confirmed by hydrogen/deuterium exchange MS and molecular dynamics simulations. Our results are further supported by cellular assays in which we assessed cell viability and phosphorylation profiles in cells expressing B-Raf(WT) or B-Raf(V600E) in response to vemurafenib or sorafenib. Our data indicate that an overall stabilization of the B-Raf structure by specific inhibitors activates MAPK signaling and increases cell survival, helping to explain clinical treatment failure. We also applied our method to monitor conformational changes upon nucleotide binding of the pseudokinase KSR1, which holds high potential for inhibition in human diseases.},
  author       = {Di Michele, Michela and Stes, Elisabeth and Vandermarliere, Elien and Arora, Rohit and Astorga-Wells, Juan and Vandenbussche, Jonathan and van Heerde, Erika and Zubarev, Roman and Bonnet, Pascal and Linders, Joannes TM and Jacoby, Edgar and Brehmer, Dirk and Martens, Lennart and Gevaert, Kris},
  issn         = {1535-3893},
  journal      = {JOURNAL OF PROTEOME RESEARCH},
  keyword      = {DRUG DISCOVERY,STRUCTURAL BASIS,MAPK PATHWAY,B-RAF,CANCER,BRAF,RAF KINASE,KINASE INHIBITORS,HYDROGEN-EXCHANGE,EXCHANGE MASS-SPECTROMETRY,small molecule,protein structure,method development,limited proteolysis,inhibitor,KSR1,kinase switch mechanism,kinase,conformational change,B-Raf},
  language     = {eng},
  number       = {10},
  pages        = {4179--4193},
  title        = {Limited proteolysis combined with stable isotope labeling reveals conformational changes in protein (pseudo)kinases upon binding small molecules},
  url          = {http://dx.doi.org/10.1021/acs.jproteome.5b00282},
  volume       = {14},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: